CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Guangxi Wuzhou Zhongheng Group, Ltd. Company Snapshot
Guangxi Wuzhou Zhongheng Group, Ltd. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Guangxi Wuzhou Zhongheng Group, Ltd. with three other companies in this sector in China: Guangdong Zhongsheng Pharmaceutical Co Ltd (2016 sales of 1.69 billion Chinese Renmimbi [US$255.50 million] of which 93% was Medicine Manufacture), Jiang Zhong Pharmaceutical Co Ltd (1.56 billion Chinese Renmimbi [US$235.74 million] of which 100% was Medical Industry), and Shanghai Shenqi Pharmaceutical Investment Management CoLtd (1.60 billion Chinese Renmimbi [US$241.23 million] of which 83% was Pharmaceutical).

Sales Analysis. During the year ended December of 2016, sales at Guangxi Wuzhou Zhongheng Group, Ltd. were 1.67 billion Chinese Renmimbi (US$252.06 million). This is an increase of 25.8% versus 2015, when the company's sales were 1.33 billion Chinese Renmimbi. Despite this increase, sales are still well below the level achieved in 2014, when Guangxi Wuzhou Zhongheng Group, Ltd. reported sales of 3.21 billion Chinese Renmimbi. Sales of Pharmaceutical Segment saw an increase of 27.5% in 2016, from 1.23 billion Chinese Renmimbi to 1.56 billion Chinese Renmimbi. Not all segments of Guangxi Wuzhou Zhongheng Group, Ltd. experienced an increase in sales in 2016: sales of Real Estate fell 76.8% to 5.61 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Guangxi Wuzhou Zhongheng Group, Ltd.
  Stock Performance Chart for Guangxi Wuzhou Zhongheng Group, Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (10/13/2017): 4.42
(Figures in Chinese Renmimbi)
1 Week n/a   13 Weeks 1.4%  
4 Weeks 10.5%   52 Weeks -0.7%  
 
Guangxi Wuzhou Zhongheng Group, Ltd. Key Data:
  Ticker: 600252 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 1,669,604,966
(Year Ending Jan 2017).
Employees: 2,194
  Currency: Chinese Renmimbi Market Cap: 15,359,973,590
  Fiscal Yr Ends: December Shares Outstanding: 3,475,107,147
  Share Type: A Gu Closely Held Shares: 834,479,949
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.